US FDA Employs Familiar Strategy In Ending Novo’s Wegovy, Ozempic Shortage

 
• By Sue Sutter
  
Empty shelves
The FDA said the shortage of Novo Nordisk's Wegovy and Ozempic is over. (Shutterstock)

More from Distribution/Supply Chain

More from Legal & IP